Back to search
Atypical Parkinsonism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Parkinsonism trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Parkinsonism trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in…
Multiple system atrophy is a rare, rapidly progressive neurodegenerative disease characterized by variable combinations of parkinsonism, cerebellar ataxia, and…
The proposed research aims to investigate the use of speech amplification devices as a potential treatment option for people with Parkinson's disease and relate…
The goal of this observational study is to learn about the impact of the different types of pain and of the domains involved in the autonomic disorders of inpat…
The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is u…
Clinical diagnosis of Parkinson's disease (PD), multiple system atrophy (MSA) and dementia with Lewy bodies (DLB) is challenging, especially in the early stages…
This pilot study evaluated the safety, tolerability, and exploratory epigenetic outcomes of a single same-day autologous bone marrow procedure in adults with Pa…
The purpose of this study is to investigate whether speed-dependent measures of gait (so called gait signatures) can be identified in patients with neurological…